Conflict of interest: Nothing to declare.
Successful treatment of pediatric plasmacytoid dendritic cell tumors with a contemporary regimen for acute lymphoblastic leukemia†
Article first published online: 15 FEB 2013
Copyright © 2013 Wiley Periodicals, Inc.
Pediatric Blood & Cancer
Volume 60, Issue 7, pages E38–E41, July 2013
How to Cite
Wright, K. D., Onciu, M. M., Coustan-Smith, E., Campana, D., Raimondi, S. C., Inaba, H., Ribeiro, R., Pui, C.-H. and Sandlund, J. T. (2013), Successful treatment of pediatric plasmacytoid dendritic cell tumors with a contemporary regimen for acute lymphoblastic leukemia. Pediatr. Blood Cancer, 60: E38–E41. doi: 10.1002/pbc.24483
- Issue published online: 22 MAY 2013
- Article first published online: 15 FEB 2013
- Manuscript Accepted: 3 JAN 2013
- Manuscript Received: 5 SEP 2012
- dendritic cell;
- hematodermic tumors;
Dendritic cell leukemia (DCL) or hematodermic tumor is an uncommon subtype of acute leukemia. In contrast to adult cases, children tend to have a less aggressive course. The diagnosis of DCL should be considered when its characteristic morphologic features are present and leukemic cells co-express CD4 and CD56. Cases of DCL among pediatric patients have been reported to respond to therapeutic regimens for acute lymphoblastic leukemia, but details regarding the specifics of therapy are lacking. Pediatr Blood Cancer 2013; 60: E38–E41. © 2013 Wiley Periodicals, Inc.